CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Sector dividends Charles River Laboratories International, Inc.

Stocks

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - NYSE Other stock markets 04:00:02 2026-06-18 pm EDT			5-day change	1st Jan Change
185.00 ^USD	+1.46%		-1.34%	-7.26%

Jun. 18	Charles River Laboratories International, Inc. and Eli Lilly and Company Enter Collaboration to Optimize Ai/Ml Platform Through Nonclinical Testing Expertise	CI
Jun. 18	Rothschild & Co Redburn Adjusts Charles River Laboratories International PT to $241 From $230, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Dividend Yield (Y)	Dividend Yield (Y+1)	P/E (Y)	Price to Book (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Capi.($)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-.--%	-.--%	30.16x	2.7x	2.78x	10.87x	13.19x	8.91B
LONZA GROUP AG	1.09%	1.25%	30.11x	3.86x	5.34x	16.53x	23.2x	43.13B
REVOLUTION MEDICINES, INC.	-.--%	-.--%	-20.5x	14.96x	304.3x	-18.74x	-18.42x	34.65B
BEONE MEDICINES AG	-.--%	-.--%	40.3x	6.01x	4.01x	25.68x	30.39x	30.03B
IQVIA HOLDINGS INC.	-.--%	-.--%	20.41x	3.87x	2.41x	10.42x	15.88x	28B
CELLTRION, INC.	0.44%	0.47%	28.67x	2.11x	7.42x	19.09x	22.78x	24.45B
MEDPACE HOLDINGS, INC.	-.--%	-.--%	27x	13.53x	4.32x	19.66x	20.62x	13.14B
EUROFINS SCIENTIFIC SE	1.23%	1.43%	21.71x	2.27x	1.89x	8.32x	13.18x	12.53B
IONIS PHARMACEUTICALS, INC.	-.--%	-.--%	-20.52x	306.12x	13.52x	-20.12x	-19.56x	12.25B
ICON PUBLIC LIMITED COMPANY	-.--%	-.--%	22.96x	1.14x	1.69x	10.24x	11.72x	11.18B
TEMPUS AI, INC.	-.--%	-.--%	-25.25x	22.53x	6.13x	150.44x	-473.44x	9.13B
BIO-TECHNE CORPORATION	0.55%	0.55%	49.69x	4.21x	7.45x	21.12x	23.13x	9.07B
PRAXIS PRECISION MEDICINES, INC.	-.--%	-.--%	-18.61x	7.03x	1612.58x	-15.46x	-14.72x	7.87B
ABIVAX	-.--%	-.--%	-22.11x	38.43x	1676.07x	-23.91x	-24.5x	7.77B
QIAGEN N.V.	-.--%	0.51%	17.62x	2.01x	3.79x	10.09x	12.93x	7.64B
ALKERMES PLC	-.--%	-.--%	-113.14x	4.07x	4.67x	24.78x	148.84x	7.5B
KYMERA THERAPEUTICS, INC.	-.--%	-.--%	-25.67x	6.61x	72.2x	-16.2x	-15.63x	7.44B
PROTAGONIST THERAPEUTICS, INC.	-.--%	-.--%	28.95x	-	13.13x	23.39x	25.43x	7.26B
IMMUNOVANT, INC.	-.--%	-.--%	-13.57x	8.25x	-	-11.3x	-11.7x	7.26B
Average	0.17%	0.22%	3.06x	24.98x	207.98x	12.89x	-11.40x	15.22B
Weighted average by Cap.	0.27%	0.32%	10.65x	20.47x	134.68x	11.79x	-1.72x